DEXOMART

Dexlansoprazole 30 mg delayed-release capsules offer an advanced solution for managing gastroesophageal reflux disease (GERD) and erosive esophagitis. As a potent proton pump inhibitor (PPI), dexlansoprazole features a unique dual delayed-release formulation that ensures extended acid suppression, providing effective symptom relief and promoting esophageal healing with a once-daily dose. Ideal for healthcare providers and pharmaceutical distributors, this medication enhances patient compliance and outcomes, making it a valuable addition to your gastrointestinal treatment portfolio.